FirstRanker.com
Firstranker's choice FirstRanker.com
Seat No.: Enrolment No.
--- Content provided by FirstRanker.com ---
GUJARAT TECHNOLOGICAL UNIVERSITY
B.Ph. - SEMESTER-8 « EXAMINATION - SUMMER-2018
Subject Code:2280011 Date: 09/05/2018
Subject Name: Drug Approval Process
Time:10:30am to 01:30pm Total Marks: 80
--- Content provided by FirstRanker.com ---
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1 (a) Explain various phases of drug development. 06
--- Content provided by FirstRanker.com ---
(b) What is investigational new drug (IND)? Explain types of INDs. 05(c) Enlist various section of IND application. Give Format of application. 05
Q.2 (a) What is Orange Book ? List the contents of orange book. Describe coding 10
system for therapeutic equivalence evaluation.
(b) Define bioequivalence. How is it performed? State statistical criteria of 06
--- Content provided by FirstRanker.com ---
Bioequivalence? Q.3 (a) How to make a FOIA request? Which information is exempted from FOIA? 06
(b) What is DMF? Enlist type of DMF. Discuss DMF Type II. 05
(c) Write note on Inactive Ingredients Guidelines. 05
Q.4 (a) Write short note on ANVISA. 06
--- Content provided by FirstRanker.com ---
(b) Discuss the WHO certification scheme for pharmaceutical products. 05(c) Write brief note on TGA. 05
Q.5 (a) States the goals of NDA. Discuss general requirements of NDA. 06
(b) Prepare a NDA chart showing NDA review process 05
(c) Write note on:supplement NDA. 05
--- Content provided by FirstRanker.com ---
Q.6 (a) Outline steps taken by CDSCO in February 2015 in making its services 06
responsive, effective and transparent.
(b) Write a note on ANDA. Explain the concept of PARA I to IV filling. 05
(c) What is SUPAC? Discuss the SUPAC guidelines for Immediate release dosage 05
forms.
--- Content provided by FirstRanker.com ---
Q.7 (a) What is CTD? Discuss structure of CTD. How it differs from eCTD. 06
(b) Describe the activity regulated by MHRA. 05
(c) How approval of bio-similar differs from NDA? 05
--- Content provided by FirstRanker.com ---
This download link is referred from the post: GTU B.Pharma 2018 Summer Question Papers || Gujarat Technological University